Clinical Trials

    A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

    Investigator: Joseph Imbs

    Study Coordinator: Daniel Arnaud Dominguez

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT06765668

    Phone: 346.356.3635

    Protocol Number: PRO00040448

    Description


    The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).